表紙
市場調查報告書
商品編碼
1034706

基因檢測的全球市場預測(按應用/技術)--COVID-19 大流行影響和更新,執行/顧問指南:2022-2026

Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic impact With Executive and Consultant Guides 2022 to 2026

出版日期: | 出版商: Howe Sound Research | 英文 490 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

遺傳學在健康和疾病中的作用現在正在被理解。這種新知識與較低的價格相結合,導致基因檢測行業出現創紀錄的增長。新藥可能只對具有特定基因的人有效,這也推動了基因檢測行業的發展。傳統基因檢測市場規模不斷擴大,檢測種類不斷增加,給行業帶來了新的氣息和問題。

本報告對全球基因檢測市場進行研究和分析,並提供14個國家和5個地區的詳細細分的系統信息。

目錄

第 1 章市場指南

第二章介紹和市場定義

第 3 章市場概覽

  • 公司進入市場的各種角色
  • 基因檢測-類型、示例、注意事項
  • 產業結構

第 4 章市場趨勢

  • 生長促進劑
  • 生長抑製劑
  • 儀器儀表和自動化
  • 診斷技術的發展

第 5 章基因檢測的最新發展

  • Tesis Labs 籌集了 2000 萬美元
  • Sema4:Sema4 的元素
  • Clarified Precision Medicine 收購 Interpares Biomedicine
  • Genetic Technologies 收購 DTC 基因檢測提供商 EasyDNA
  • Illumina 和比利時遺傳中心合作開發基於 WGS 的 Dx
  • NIH 和 Genomics England 開始使用納米孔技術進行測序研究
  • Progenity 的銷售額因 COVID-19 的影響而下降
  • Natera 宣佈癌症基因組譜分析等。

第六章主要公司簡介

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Diagnostics
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agena Bioscience, Inc.
  • Agilent/Dako
  • Akonni Biosystems
  • Ancestry.com LLC
  • Anchor Dx
  • Arc Bio
  • ARUP Laboratories
  • Asuragen
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • C2i Genomics
  • Cancer Genetics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Cepheid (Danaher)
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • Cynvenio
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Exosome Diagnostics
  • Fabric Genomics
  • Fluidigm Corp
  • Foundation Medicine
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneFirst Ltd.
  • Genetic Technologies Ltd.
  • Genetron Holdings
  • Genomics England
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grail, Inc.
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helomics
  • Hologic
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech (Thermo Fisher)
  • MIODx
  • miR Scientific
  • MNG Labs
  • Molecular MD
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • NGeneBio
  • Novogene Bioinformatics Technology Co., Ltd.
  • Omega Bioservices
  • OncoDNA
  • OpGen
  • ORIG3N, Inc.
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen Gmbh
  • Quantumdx
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sema4 Holdings
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • SkylineDx
  • Stratos Genomics
  • Sure Genomics, Inc.
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Tesis Labs
  • Thermo Fisher Scientific Inc.
  • Variantyx
  • Veritas Genetics
  • Volition

第 7 章全球市場規模

  • 世界市場:按國家/地區
  • 全球市場:按應用
  • 世界市場:按技術
  • 全球市場:按產品分類
  • 世界市場:按用戶

第 8 章市場規模:按用途

  • 新生兒檢測市場
  • NIPT 市場
  • 預測檢驗市場
  • 腫瘤檢測市場
  • DTC檢驗市場
  • 其他檢驗市場

第 9 章全球基因檢測市場:按技術

  • PCR 檢測市場
  • NGS 市場
  • 細胞遺傳學檢測市場
  • 其他檢驗市場

第 10 章全球基因檢測市場:按產品

  • 儀器市場
  • 試劑/試劑盒市場
  • 軟件市場
  • 服務市場

第 11 章全球基因檢測市場:按用戶

  • 學術市場
  • 臨床市場
  • 醫藥市場
  • 工業/其他市場

第 12 章基因檢測的未來

第 13 章附錄

目錄

OVERVIEW:

Is genomic cancer testing bouncing back? What has happened to Direct to Consumer testing? Will all newborns receive Whole Genomic Sequencing at birth?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer?Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Genetic Testing - Strategic Situation Analysis & Company Rankings
    • 1.1.1. Selected Genetic Testing Companies Revenue & Growth
    • 1.1.2. Selected Companies Growth Chart
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. Genetic Testing Definition in This Report
  • 2.2. The Genomics Revolution
  • 2.3. Market Definition
    • 2.3.1. Revenue Market Size.
    • 2.3.2. Newborn Screening
    • 2.3.3. Non Invasise Pregnancy Testing
    • 2.3.4. Predictive
    • 2.3.5. Oncology
    • 2.3.6. Direct to Consumer
    • 2.3.7. Other Application
    • 2.3.8. PCR
    • 2.3.9. NGS
    • 2.3.10. Cytogenetic
    • 2.3.11. Other Technology
  • 2.4. Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics
  • 2.5. Chromosomes, Genes and Epigenetics
    • 2.5.1. Chromosomes
    • 2.5.2. Genes
    • 2.5.3. Epigenetics

3. Market Overview

  • 3.1. Market Participants Play Different Roles
    • 3.1.1. Supplier/pharmaceutical
    • 3.1.2. Independent lab specialized/esoteric
    • 3.1.3. Independent lab national/regional
    • 3.1.4. Independent lab analytical
    • 3.1.5. Public National/regional lab
    • 3.1.6. Hospital lab
    • 3.1.7. Physician lab
    • 3.1.8. DTC Lab
    • 3.1.9. Independent Genetic Testing Lab
    • 3.1.10. Audit Body
  • 3.2. Genetic Tests - Types, Examples and Discussion
    • 3.2.1. Preimplantation Genetic Diagnosis- An Emerging Market
    • 3.2.2. Prenatal Diagnosis - New Technologies Create Opportunity
    • 3.2.3. Newborn Screening
    • 3.2.4. Diagnostic Testing
    • 3.2.5. Carrier Testing
    • 3.2.6. Predictive and Presymptomatic Testing
    • 3.2.7. Pharmacogenomics
    • 3.2.8. Forensic Testing
    • 3.2.9. Parental Testing
    • 3.2.10. Ancestral Testing
  • 3.3. Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Genetic Discoveries Creating New Diagnostic Markets.
    • 4.1.2. Aging Population a Boon for Diagnostics
    • 4.1.3. Pharmacogenomics Drives Further Growth.
    • 4.1.4. Oncology and Liquid Biopsy Enter New Era
    • 4.1.5. Fertility Practice Growth drives market
    • 4.1.6. Direct to Consumer begins to break out
  • 4.2. Factors Limiting Growth
    • 4.2.1. Increased Competition Lowers Price
    • 4.2.2. Lower Costs
    • 4.2.3. Testing usage analysis curtailing growth
    • 4.2.4. Wellness has a downside
  • 4.3. Instrumentation and Automation
    • 4.3.1. Instruments Key to Market Share
    • 4.3.2. Bioinformatics Plays a Role
  • 4.4. Diagnostic Technology Development
    • 4.4.1. Next Generation Sequencing Fuels a Revolution
    • 4.4.2. Impact of NGS on pricing
    • 4.4.3. POCT/Self Testing Disruptive Force
    • 4.4.4. Pharmacogenomics Blurs Diagnosis and Treatment
    • 4.4.5. CGES Testing, A Brave New World
    • 4.4.6. Biochips/Giant magneto resistance-based assay

5. Genetic Testing Recent Developments

  • 5.1.1. Importance of This Section
  • 5.1.2. How to Use This Section
  • 5.2. Tesis Labs Raises $20M
  • 5.3. Sema4: Sema4 Elements
  • 5.4. Clarified Precision Medicine Acquires Interpares Biomedicine
  • 5.5. Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • 5.6. Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
  • 5.7. NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
  • 5.8. Progenity Revenues Fall on COVID-19 Effect
  • 5.9. Natera Launches Tumor Genomic Profiling Assay
  • 5.10. 23andMe To Go Public
  • 5.11. Guardant Health to Offer Tumor Tissue Sequencing
  • 5.12. Ancestry Quits Health Offering
  • 5.13. DTC Firm MyDNA Merges With Gene by Gene
  • 5.14. Aetna Coverage for NIPT to Include All Pregnancies
  • 5.15. Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
  • 5.16. Tumor, Germline Testing of Cancer Patients Can Give Discordant Results
  • 5.17. Invitae Completes Acquisition of ArcherDx
  • 5.18. Prenetics Receives $15M Investment
  • 5.19. Sanford Health Invests $800K in TruGenomix as Part of PTSD Test Alliance
  • 5.20. Preconception Carrier Screening Trial Begins in Australia
  • 5.21. Genetic Testing Clinical Use Just Beginning
  • 5.22. Fulgent Genetics Q1 Revenues Jump 44 Percent
  • 5.23. Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders
  • 5.24. Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests
  • 5.25. Invitae Acquires Three Companies: YouScript, Genelex, Diploid
  • 5.26. PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England
  • 5.27. Germline Cancer Risk Mutations Sometimes Reported in Tumor Testing
  • 5.28. Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America
  • 5.29. Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
  • 5.30. Phosphorus Offers DNA Testing to Assess Disease Risk
  • 5.31. Arivale Shuts Down Personalized Wellness Business
  • 5.32. ArcherDX Acquires Baby Genes
  • 5.33. MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay
  • 5.34. Thermo Fisher Purchases 9 Percent Stake in Yourgene Health
  • 5.35. Invitae Partners to Expand Free Epilepsy Genetic Testing Program
  • 5.36. Illumina, Chinese Firm Partner on NGS System for Genetic Disease Dx
  • 5.37. NanoString Technologies Prices $103.5M Common Stock Offering
  • 5.38. Canine Consumer Genomics Firm Embark Veterinary Raises $10M
  • 5.39. Yourgene Health to Acquire Elucigene
  • 5.40. Helix, AdventHealth Partner on Genetic Screening Study

6. Profiles of Key Companies

  • 6.1. 10x Genomics, Inc.
  • 6.2. 23andME Inc.
  • 6.3. Abbott Diagnostics
  • 6.4. Adaptive Biotechnologies
  • 6.5. Admera Health, LLC
  • 6.6. Agena Bioscience, Inc.
  • 6.7. Agilent/Dako
  • 6.8. Akonni Biosystems
  • 6.9. Ancestry.com LLC
  • 6.10. Anchor Dx
  • 6.11. Arc Bio
  • 6.12. ARUP Laboratories
  • 6.13. Asuragen
  • 6.14. Baylor Miraca Genetics Laboratories
  • 6.15. Beckman Coulter Diagnostics
  • 6.16. Becton, Dickinson and Company
  • 6.17. BGI Genomics Co. Ltd
  • 6.18. Bioarray Genetics
  • 6.19. Biocept, Inc.
  • 6.20. Biodesix Inc.
  • 6.21. BioFluidica
  • 6.22. BioGenex
  • 6.23. Biolidics Ltd
  • 6.24. bioMérieux Diagnostics
  • 6.25. Bioneer Corporation
  • 6.26. Bio-Rad Laboratories, Inc
  • 6.27. Bio-Techne
  • 6.28. C2i Genomics
  • 6.29. Cancer Genetics
  • 6.30. Caris Molecular Diagnostics
  • 6.31. CellMax Life
  • 6.32. Centogene
  • 6.33. Cepheid (Danaher)
  • 6.34. Chronix Biomedical
  • 6.35. Circulogene
  • 6.36. Clinical Genomics
  • 6.37. Color Genomics
  • 6.38. Complete Genomics, Inc. - A BGI Company
  • 6.39. Cynvenio
  • 6.40. Dante Labs
  • 6.41. Datar Cancer Genetics Limited
  • 6.42. Diasorin S.p.A.
  • 6.43. Epic Sciences
  • 6.44. Epigenomics AG
  • 6.45. Eurofins Scientific
  • 6.46. Excellerate Bioscience
  • 6.47. Exosome Diagnostics
  • 6.48. Fabric Genomics
  • 6.49. Fluidigm Corp
  • 6.50. Foundation Medicine
  • 6.51. Freenome
  • 6.52. FUJIFILM Wako Diagnostics
  • 6.53. Fujirebio
  • 6.54. Fulgent Genetics
  • 6.55. Gene by Gene, Ltd.
  • 6.56. Genedrive
  • 6.57. GeneFirst Ltd.
  • 6.58. Genetic Technologies Ltd.
  • 6.59. Genetron Holdings
  • 6.60. Genomics England
  • 6.61. Genomics Personalized Health (GPH)
  • 6.62. GenomOncology
  • 6.63. Genzyme Corporation
  • 6.64. Grail, Inc.
  • 6.65. Grifols
  • 6.66. Guardant Health
  • 6.67. Guardiome
  • 6.68. HeiScreen
  • 6.69. Helix
  • 6.70. Helomics
  • 6.71. Hologic
  • 6.72. Horizon Discovery
  • 6.73. HTG Molecular Diagnostics
  • 6.74. Human Longevity, Inc.
  • 6.75. iCellate
  • 6.76. Illumina
  • 6.77. Incell Dx
  • 6.78. Inivata
  • 6.79. Integrated Diagnostics
  • 6.80. Invitae Corporation
  • 6.81. Invivoscribe
  • 6.82. Karius
  • 6.83. Macrogen
  • 6.84. MDNA Life SCIENCES, Inc.
  • 6.85. MDx Health
  • 6.86. Medgenome
  • 6.87. Meridian Bioscience
  • 6.88. Mesa Biotech (Thermo Fisher)
  • 6.89. MIODx
  • 6.90. miR Scientific
  • 6.91. MNG Labs
  • 6.92. Molecular MD
  • 6.93. NantHealth, Inc.
  • 6.94. Natera
  • 6.95. Nebula Genomics
  • 6.96. NeoGenomics
  • 6.97. NGeneBio
  • 6.98. Novogene Bioinformatics Technology Co., Ltd.
  • 6.99. Omega Bioservices
  • 6.100. OncoDNA
  • 6.101. OpGen
  • 6.102. ORIG3N, Inc.
  • 6.103. Origene Technologies
  • 6.104. Oxford Nanopore Technologies
  • 6.105. Panagene
  • 6.106. Perkin Elmer
  • 6.107. Personal Genome Diagnostics
  • 6.108. Personalis
  • 6.109. Precipio
  • 6.110. PrecisionMed
  • 6.111. Promega
  • 6.112. Protagen Diagnostics
  • 6.113. Qiagen Gmbh
  • 6.114. Quantumdx
  • 6.115. Roche Molecular Diagnostics
  • 6.116. Roswell Biotechnologies
  • 6.117. Seegene
  • 6.118. Sema4 Holdings
  • 6.119. Sequencing.com
  • 6.120. Siemens Healthineers
  • 6.121. simfo GmbH
  • 6.122. Singlera Genomics Inc.
  • 6.123. SkylineDx
  • 6.124. Stratos Genomics
  • 6.125. Sure Genomics, Inc.
  • 6.126. Sysmex
  • 6.127. Sysmex Inostics
  • 6.128. Tempus Labs, Inc.
  • 6.129. Tesis Labs
  • 6.130. Thermo Fisher Scientific Inc.
  • 6.131. Variantyx
  • 6.132. Veritas Genetics
  • 6.133. Volition

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table - Global Market by Technology
    • 7.3.2. Chart - Technology Share by Year
    • 7.3.3. Chart - Technology Segment Growth Rates
    • 7.3.4. Chart - Technology Segment Share Shifts
    • 7.3.5. Chart - Technology Segment Share Base Year
    • 7.3.6. Chart - Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Product Share by Year
    • 7.4.3. Chart - Product Segment Growth Rates
    • 7.4.4. Chart - Product Segment Share Shifts
    • 7.4.5. Chart - Product Segment Share Base Year
    • 7.4.6. Chart - Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table - Global Market by User
    • 7.5.2. Chart - User Share by Year
    • 7.5.3. Chart - User Segment Growth Rates
    • 7.5.4. Chart - User Segment Share Shifts
    • 7.5.5. Chart - User Segment Share Base Year
    • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Newborn Testing Market
    • 8.1.1. Table Newborn - by Country
    • 8.1.2. Chart - Newborn Growth
  • 8.2. NIPT Market
    • 8.2.1. Table NIPT - by Country
    • 8.2.2. Chart - NIPT Growth
  • 8.3. Predictive Testing Market
    • 8.3.1. Table Predictive - by Country
    • 8.3.2. Chart - Predictive Growth
  • 8.4. Oncology Testing Market
    • 8.4.1. Table Oncology - by Country
    • 8.4.2. Chart - Oncology Growth
  • 8.5. DTC Testing Market
    • 8.5.1. Table DTC - by Country
    • 8.5.2. Chart - DTC Growth
  • 8.6. Other Testing Market
    • 8.6.1. Table Other - by Country
    • 8.6.2. Chart - Other Growth

9. Global Genetic Testing Market by Technology

  • 9.1. PCR Testing Market
    • 9.1.1. Table PCR - by Country
    • 9.1.2. Chart - PCR Growth
  • 9.2. NGS Market
    • 9.2.1. Table NGS - by Country
    • 9.2.2. Chart - NGS Growth
  • 9.3. Cytogenetic Testing Market
    • 9.3.1. Table Cytogenetic - by Country
    • 9.3.2. Cytogenetic - Predictive Growth
  • 9.4. Other Testing Market
    • 9.4.1. Table Other - by Country
    • 9.4.2. Chart - Other Growth

10. Global Genetic Testing Market by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits - by Country
    • 10.2.2. Chart - Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software - by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services - by Country
    • 10.4.2. Chart - Services Growth

11. Global Genetic Testing Market by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic - by Country
    • 11.1.2. Chart - Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical - by Country
    • 11.2.2. Chart - Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical - by Country
    • 11.3.2. Pharmaceutical - Predictive Growth
  • 11.4. Industrial and Other Market
    • 11.4.1. Table Industrial and Other - by Country
    • 11.4.2. Chart - Industrial and Other Growth

12. The Future of Genetic Testing

13. Appendices

  • 13.1. United States Medicare System: 2021 laboratory Fees Schedule
  • 13.2. II Methodology
    • 13.2.1. II.1 Authors
    • 13.2.2. II.2 Sources

Table of Tables

  • Table 1: Leading Genomic Companies Revenue Growth (USD $M)
  • Table 2: Most Common Traditional Genetic Disorders
  • Table 3: The Base Pairs
  • Table 4: Market Players by Type
  • Table 5: The Different Types of Genetic Tests
  • Table 6: Five Factors Driving Growth
  • Table 7: Four Factors Limiting Growth
  • Table 8: Key Diagnostic Laboratory Technology Trends
  • Table 9: Next Generation Sequencing Technologies - Speed and Cost
  • Table 10: Global Market by Country
  • Table 11: Global Market by Application
  • Table 12: Global Market by Technology
  • Table 13: Global Market by Product
  • Table 14: Global Market by User
  • Table 15: Newborn Segment by Country
  • Table 16: NIPT Segment by Country
  • Table 17: Predictive Segment by Country
  • Table 18: Oncology Segment by Country
  • Table 19: DTC Segment by Country
  • Table 20: Other Segment by Country
  • Table 21: PCR Segment by Country
  • Table 22: NGS Segment by Country
  • Table 23: Cytogenetic Segment by Country
  • Table 24: Other Segment by Country
  • Table 25: Instruments Segment by Country
  • Table 26: Reagents and Kits Segment by Country
  • Table 27: Software Segment by Country
  • Table 28: Services Segment by Country
  • Table 29: Academic Segment by Country
  • Table 30: Clinical Segment by Country
  • Table 31: Pharmaceutical Segment by Country
  • Table 32: Industrial and Other Segment by Country
  • Table 33: 2021 CLINICAL LAB FEE SCHEDULE

Table of Figures

  • Figure 1: The Lab Test Pie
  • Figure 2: DNA Strands and Chromosomes
  • Figure 3: Karyogram of Human Chromosomes
  • Figure 4: Size of Various Genomes
  • Figure 5: Percentage of World Population Over 65
  • Figure 6: Country Market Shares
  • Figure 7: Application Share by Year
  • Figure 8: Application Segment Growth Rates
  • Figure 9: Segment Share Shifts
  • Figure 10: Application Segment Share Base Year
  • Figure 11: Application Segment Share Final Year
  • Figure 12: Technology Share by Year
  • Figure 13: Technology Segment Growth Rates
  • Figure 14: Technology Segment Share Shifts
  • Figure 15: Technology Segment Share Base Year
  • Figure 16: Technology Segment Share Final Year
  • Figure 17: Product Share by Year
  • Figure 18: Product Segment Growth Rates
  • Figure 19: Product Segment Share Shifts
  • Figure 20: Product Segment Share Base Year
  • Figure 21: Product Segment Share Final Year
  • Figure 22: User Share by Year
  • Figure 23: User Segment Growth Rates
  • Figure 24: User Segment Share Shifts
  • Figure 25: User Segment Share Base Year
  • Figure 26: User Segment Share Final Year
  • Figure 27: Newborn vs. Total Market Growth
  • Figure 28: NIPT vs. Total Market Growth
  • Figure 29: Predictive vs. Total Market Growth
  • Figure 30: Oncology vs. Total Market Growth
  • Figure 31: DTC vs. Total Market Growth
  • Figure 32: Other vs. Total Market Growth
  • Figure 33: PCR vs. Total Market Growth
  • Figure 34: NGS vs. Total Market Growth
  • Figure 35: Cytogenetic vs. Total Market Growth
  • Figure 36: Other vs. Total Market Growth
  • Figure 37: Instrument vs. Total Market Growth
  • Figure 38: Reagents and Kits vs. Total Market Growth
  • Figure 39: Software vs. Total Market Growth
  • Figure 40: Services vs. Total Market Growth
  • Figure 41: Academic vs. Total Market Growth
  • Figure 42: Clinical vs. Total Market Growth
  • Figure 43: Pharmaceutical vs. Total Market Growth
  • Figure 44: Industrial and Other vs. Total Market Growth